Latest News about covid/19
Recent news which mentions covid/19
Long Covid Remains Diagnostic Mystery, Diagnosis Remains Elusive; National Institutes of Health-Funded Study Shows
August 13, 2024
From Benzinga
Markets Experience Best And Worst Days Since 2022: What's Next In Wall Street's Rollercoaster Ride?
August 12, 2024
From Benzinga
Mark Zuckerberg's Meta Platforms Triumphs Over Independent Presidential Candidate Robert Kennedy Jr.'s Anti-Vaccine Group In Censorship Lawsuit
August 09, 2024
From Benzinga
Biden won't drop out, campaign insists in a new memo
July 19, 2024
From CNBC.com News
COVID Activity Is Elevated Across 26 States In Summer Surge, Biden Remains In Isolation: 3 Vaccine Stocks To Watch
July 18, 2024
From Benzinga
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
June 28, 2024
From CNBC.com News
From Benzinga
Mark Cuban Uses Hypothetical Space Virus Spread By Star Trek Aliens On Mars To Make A Point About Vaccines To Elon Musk
June 09, 2024
Tickers
NEWS
From Benzinga
From Benzinga
From Benzinga
Novavax Stock Soars On FDA COVID-19 Update: Fundamental Rally Or Potential Short Squeeze?
June 06, 2024
Tickers
NVAX
From Benzinga
From Benzinga
Fauci Addresses COVID-19 Origins Before House Oversight Committee, Says Family Faced Harassment
June 04, 2024
Tickers
NEWS
From Benzinga
FLiRT variants may lead to a Covid surge this summer: 7 ways to boost your immune system
May 24, 2024
From CNBC.com News
From Benzinga
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
May 17, 2024
From Benzinga
AstraZeneca's COVID-19 Prevention Therapy Cuts Risk Of Infection In Patients With Weaker Immunity, Data Shows
May 16, 2024
From Benzinga
From CNBC.com News
This inflation-focused ETF may be in a sweet spot
May 11, 2024
From CNBC.com News
From Benzinga
From Benzinga
Pfizer Sees Less Revenue From Covid-19 Treatments, Stock Faces Headwinds Ahead Of Q1 Earnings
April 30, 2024
From Benzinga
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown
April 23, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.